Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

May 01, 2005; Volume 25,Issue 3A

Proccedings of the 12th International Hamburg Symposium on Tumor Markers, November 30 - December 2, 2003, Hamburg, Germany

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Akcetin, Z.

    1. You have access
      Radiochemotherapy after Transurethral Resection is an Effective Treatment Method in T1G3 Bladder Cancer
      Z. AKÇETIN, J. TODOROV, E. TÜZEL, D.G. ENGEHAUSEN, F.S. KRAUSE, R. SAUER, K.M. SCHROTT and C. RÖDEL
      Anticancer Research May 2005, 25 (3A) 1623-1628;
    2. You have access
      Does the Distance to Normal Renal Parenchyma (DTNRP) in Nephron-sparing Surgery for Renal Cell Carcinoma have an Effect on Survival?
      Z. AKÇETIN, V. ZUGOR, D. ELSÄSSER, F.S. KRAUSE, B. LAUSEN, K.M. SCHROTT and D.G. ENGEHAUSEN
      Anticancer Research May 2005, 25 (3A) 1629-1632;
  2. Akcetin, ZIYA

    1. You have access
      Polymorphisms in the Human Progesterone Receptor (PGR) Gene of Two Human Prostate Adenocarcinoma Cell Lines
      DIRK G. ENGEHAUSEN, SABINE ENDELE, STEFFEN F. KRAUSE, TORSTEN RITH, KARL M. SCHROTT and ZIYA AKCETIN
      Anticancer Research May 2005, 25 (3A) 1607-1609;
    2. You have access
      Polymorphisms of Human Androgen Receptor (hAR) Gene in Prostate Cancer Cell Lines PC-EW and PC-OR
      DIRK G. ENGEHAUSEN, F. STEFFEN KRAUSE, JOHANN FLEISCHMANN, ZIYA AKCETIN, KARL M. SCHROTT and SABINE ENDELE
      Anticancer Research May 2005, 25 (3A) 1611-1614;
  3. Akcetin, ZIYA Y.

    1. You have access
      Heterogeneity in Prostate Cancer: Prostate Specific Antigen (PSA) and DNA Cytophotometry
      F. STEFFEN KRAUSE, GERHARD FEIL, KARL-HORST BICHLER, KARL M. SCHROTT, ZIYA Y. AKCETIN and DIRK G. ENGEHAUSEN
      Anticancer Research May 2005, 25 (3A) 1783-1785;
  4. Alberti, WINFIRED

    1. You have access
      Combination of Immunomagnetic Enrichment with Multiplex RT-PCR Analysis for the Detection of Disseminated Tumor Cells
      VEIT ZIEGLSCHMID, CHRISTIANE HOLLMANN, BERTHA GUTIERREZ, WINFIRED ALBERTI, DARK STROTHOFF, EBERHARD GROSS and OLIVER BÖCHER
      Anticancer Research May 2005, 25 (3A) 1803-1810;
  5. Alicarte, JULIAN

    1. You have access
      Pro-gastrin-releasing Peptide (ProGRP) in Patients with Benign and Malignant Diseases: Comparison with CEA, SCC, CYFRA 21-1 and NSE in Patients with Lung Cancer
      RAFAEL MOLINA, JOSE M. AUGE, XAVIER FILELLA, NURIA VIÑOLAS, JULIAN ALICARTE, JOSE M. DOMINGO and ANTONIO M. BALLESTA
      Anticancer Research May 2005, 25 (3A) 1773-1778;
  6. Auge, J.M.

    1. You have access
      S-100β and MIA in Advanced Melanoma in Relation to Prognostic Factors
      J.M. AUGE, R. MOLINA, X. FILELLA, E. BOSCH, M. GONZALEZ CAO, S. PUIG, J. MALVEHY, T. CASTEL and A.M. BALLESTA
      Anticancer Research May 2005, 25 (3A) 1779-1782;
  7. Auge, JOSE M.

    1. You have access
      CYFRA 21.1 in Patients with Cervical Cancer: Comparison with SCC and CEA
      RAFAEL MOLINA, XAVIER FILELLA, JOSE M. AUGÉ, ELVIRA BOSCH, AURELI TORNE, JAUME PAHISA, JOSE A. LEJARCEGUI, ANGELS ROVIROSA, BEGONA MELLADO, JAUME ORDI and ALBERT BIETE
      Anticancer Research May 2005, 25 (3A) 1765-1771;
  8. Auge, JOSE M.

    1. You have access
      Pro-gastrin-releasing Peptide (ProGRP) in Patients with Benign and Malignant Diseases: Comparison with CEA, SCC, CYFRA 21-1 and NSE in Patients with Lung Cancer
      RAFAEL MOLINA, JOSE M. AUGE, XAVIER FILELLA, NURIA VIÑOLAS, JULIAN ALICARTE, JOSE M. DOMINGO and ANTONIO M. BALLESTA
      Anticancer Research May 2005, 25 (3A) 1773-1778;
  9. Babinsky, A.

    1. You have access
      Further Evidence for Prolongation of Survival of Pancreatic Cancer Patients by Efficacy Orientated Sequential Polychemotherapy (EOSPC) Based on Serial Tumor Marker Determinations (CA 19-9/CEA)
      R. KLAPDOR, M. BAHLO and A. BABINSKY
      Anticancer Research May 2005, 25 (3A) 1687-1691;
  10. Backe, J.

    1. You have access
      S100 as an Immunohistochemically-detected Marker with Prognostic Significance in Endometrial Carcinoma
      A. HONIG, N. SCHALLER, J. DIETL, J. BACKE and U. KAMMERER
      Anticancer Research May 2005, 25 (3A) 1747-1753;
« Previous (Pages : 1 2 3 4 5 6 ... 24) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 25 (3A)
Anticancer Research
Vol. 25, Issue 3A
1 May 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire